Home Newsfeeds Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

Moderna Receives FDA Authorization For Emergency Use Of Omicron-Targeting Bivalent COVID-19 Booster Vaccine For Adults 18 Years And Older

By Benzinga Newsdesk

August 31, 10:47 AM

Moderna's Bivalent Booster Shots to be Available Nationwide In Coming Days mRNA-1273.222 Targets BA.4/.5 Strains of Omicron Variant CAMBRIDGE, MA / ACCESSWIRE / August 31, 2022 / Moderna, Inc. (NASDAQ:MRNA), a

MRNA

Barclays Maintains Overweight on Remitly Global, Raises Price Target to $15

By Benzinga Newsdesk

January 30, 9:15 AM

Barclays analyst Raimo Lenschow maintains Remitly Global (NASDAQ:RELY) with a Overweight and raises the price target from $12 to $15.

RELY

EXCLUSIVE: OpenAI Went 5 For 5 In NFL Playoff Predictions, Here’s What It’s Saying About Super Bowl LVII

By Chris Katje

February 12, 10:07 AM

The use cases for artificial intelligence continue to rise, with ChatGPT among the most-discussed topics at the start of 2023. One area that could use AI is sports with use cases for sports betting, fan engagement and more. Here’s what one Ark Invest portfolio manager told Benzinga.

ARKQ

Pangaea Logistics Solns Q4 EPS $0.32 Beats $0.29 Estimate, Sales $127.92M Miss $157.20M Estimate

By Bill Haddad

March 15, 4:07 PM

Pangaea Logistics Solns (NASDAQ:PANL) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.29 by 10.34 percent. This is a 42.86 percent decrease over earnings of $0.56 per share

PANL

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Related Posts

Moderna Receives FDA Authorization For Emergency Use Of Omicron-Targeting Bivalent COVID-19 Booster Vaccine For Adults 18 Years And Older

Barclays Maintains Overweight on Remitly Global, Raises Price Target to $15

EXCLUSIVE: OpenAI Went 5 For 5 In NFL Playoff Predictions, Here’s What It’s Saying About Super Bowl LVII

Pangaea Logistics Solns Q4 EPS $0.32 Beats $0.29 Estimate, Sales $127.92M Miss $157.20M Estimate